Xynomic Pharmaceuticals (XYNPW) 10-Q 2019 Q3 Quarterly report

Exhibit 32.2

CERTIFICATION OF

PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Xynomic Pharmaceuticals Holdings, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2019 (the “Report”), I, Jinwei Coco Kou, Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 14, 2019	/s/ Jinwei Coco Wei
	Jinwei Coco Kou
	Chief Financial Officer and Chief Accounting Officer